Current Management of Diabetic Retinopathy
Treatment of Diabetic Retinopathy in Pregnancy
Publication
, Chapter
Finn, AP; Vajzovic, L
January 1, 2018
Management of diabetic retinopathy during pregnancy requires special consideration. It is well known that both diabetic retinopathy severity and macular edema can progress during pregnancy. Fluorescein angiography and intravitreal anti-vascular endothelial growth factor injection are typically avoided in pregnancy; however, specific exceptions do exist. This chapter reviews guidelines for evaluation and the treatment options for diabetic retinopathy and macular edema during pregnancy. The potential adverse effects and complications to consider in pregnancy are outlined.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Finn, A. P., & Vajzovic, L. (2018). Treatment of Diabetic Retinopathy in Pregnancy. In Current Management of Diabetic Retinopathy (pp. 115–121). https://doi.org/10.1016/B978-0-323-48452-7.00011-1
Finn, A. P., and L. Vajzovic. “Treatment of Diabetic Retinopathy in Pregnancy.” In Current Management of Diabetic Retinopathy, 115–21, 2018. https://doi.org/10.1016/B978-0-323-48452-7.00011-1.
Finn AP, Vajzovic L. Treatment of Diabetic Retinopathy in Pregnancy. In: Current Management of Diabetic Retinopathy. 2018. p. 115–21.
Finn, A. P., and L. Vajzovic. “Treatment of Diabetic Retinopathy in Pregnancy.” Current Management of Diabetic Retinopathy, 2018, pp. 115–21. Scopus, doi:10.1016/B978-0-323-48452-7.00011-1.
Finn AP, Vajzovic L. Treatment of Diabetic Retinopathy in Pregnancy. Current Management of Diabetic Retinopathy. 2018. p. 115–121.